Charles River Laboratories International (CRL) EBITDA Margin (2009 - 2026)
Charles River Laboratories International (CRL) recorded EBITDA Margin of 18.64% in Q2 2026, down 2.64 percentage points from 21.28% a year earlier and down 0.14 percentage points from the prior quarter.
Charles River Laboratories International (CRL) EBITDA Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Charles River Laboratories International's EBITDA Margin came in at 9.70% as of Jun 27, 2026, down 4.07 percentage points year-over-year; for FY2025, it came in at 10.67%, down 3.87 percentage points from FY2024.
- Annual EBITDA Margin has declined for four straight years, with a five-year change of -12.16 percentage points (FY2020 to FY2025).
- Across earlier years, EBITDA Margin came in at 14.55% in FY2024 (-8.01 pp), 22.55% in FY2023 (-1.46 pp), 24.01% in FY2022 (-0.15 pp) and 24.16% in FY2021 (+1.33 pp).
- Quarterly EBITDA Margin has ranged from -20.64% in Q4 2025 to 27.11% in Q2 2022 over the past five years.
- On a year-over-year basis, EBITDA Margin has declined for three consecutive quarters, with an average year-over-year change of -6.12 percentage points over the last eight quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 4.63 percentage points in Q2 2022, against a drop of 27.60 percentage points in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 18.78% (Q1 2026), -20.64% (Q4 2025) and 21.79% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 43.58 Bn | 35.28 Bn | 1.44 Bn | 18.41% |
| 2 | Medpace Holdings | 17.39 Bn | 15.45 Bn | 201.64 Mn | 21.71% |
| 3 | Charles River Laboratories International | 14.59 Bn | 13.78 Bn | 363.37 Mn | 18.64% |
| 4 | Icon | 13.27 Bn | 10.38 Bn | 479.29 Mn | 11.15% |
| 5 | Fortrea Holdings | 2.03 Bn | 1.41 Bn | 139.20 Mn | 5.07% |
| 6 | Ginkgo Bioworks Holdings | 716.57 Mn | -45.52 Mn | 18.44 Mn | -229.38% |
| 7 | Evotec SE | 506.10 Mn | -1.10 Bn | - | - |
| 8 | Champions Oncology | 66.85 Mn | 41.93 Mn | 7.70 Mn | -0.62% |
| 9 | MindWalk Holdings | 63.92 Mn | 27.58 Mn | 1.61 Mn | -152.92% |
| 10 | Natural Alternatives International | 6.75 Mn | -21.33 Mn | 1.73 Mn | -34.75% |
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 18.64% |
| Mar 28, 2026 | 18.78% |
| Dec 27, 2025 | -20.64% |
| Sep 27, 2025 | 21.79% |
| Jun 28, 2025 | 21.28% |
| Mar 29, 2025 | 19.82% |
| Dec 28, 2024 | -6.54% |
| Sep 28, 2024 | 20.36% |
| Jun 29, 2024 | 23.17% |
| Mar 30, 2024 | 20.89% |
| Dec 30, 2023 | 21.06% |
| Sep 30, 2023 | 22.44% |
| Jul 1, 2023 | 22.89% |
| Apr 1, 2023 | 23.80% |
| Dec 31, 2022 | 21.94% |
| Sep 24, 2022 | 22.81% |
| Jun 25, 2022 | 27.11% |
| Mar 26, 2022 | 24.52% |
| Dec 25, 2021 | 26.52% |
| Sep 25, 2021 | 25.06% |
Charles River Laboratories International EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CRL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CRL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CRL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();